Mie, Japan

Toshikazu Yagi

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Sumitomo Dainippon Pharma Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshikazu Yagi. Retrieved from https://idiyas.com/inventor/toshikazu-yagi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 25.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Osaka, JP (2013)
  • Mie, JP (2019 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Biography of Toshikazu Yagi

Introduction

Toshikazu Yagi is a notable inventor based in Mie, Japan. He has made significant contributions to the field of chemical production, particularly in the synthesis of complex organic compounds. With a total of four patents to his name, Yagi's work is recognized for its industrial applicability and innovation.

Latest Patents

One of his latest patents is a method for producing 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione. This invention addresses the challenge of providing a method that is suited for industrial production. The process involves reacting 3-bromo-3-buten-2-one and 2-hydroxy-1,4-naphthoquinone in the presence of a solvent. Crystals of 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione are obtained by adding an alcohol-based solvent and/or water to the reaction system. The crystals are then treated using a specific adsorbent in the presence of a solvent.

Career Highlights

Throughout his career, Toshikazu Yagi has worked with prominent companies in the pharmaceutical industry, including Sumitomo Dainippon Pharma Co., Ltd. and Dainippon Sumitomo Pharma Co., Ltd. His experience in

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…